PUBLICATIONS
Connolly M, et al. Long-term economic benefits attributed to IVF conceived children: A lifetime tax calculation. American Journal of Managed Care 2008; (in press).
Connolly M, De Vrieze K, Ombelet W, Schneider D, Currie CJ. A cost per live birth comparison based on a systematic review of hMG and rFSH randomised trials. Reproductive BioMedicine OnlineI (Accepted for publication 2008).
Connolly M, et al. Once daily mesalazine for maintaining remission is cost-saving compared to twic daily mesalazine: An economic evaluation based on the PODIUM randomised controlled trial. Abstract accepted UEGW 2008; Vienna.
Svensson A, Connolly M, Gallo F, Hägglund L. Long Term Fiscal Implications of subsidizing In-vitro Fertilization in Sweden: A lifetime tax perspective. Scandinavian Journal of Public Health (in press).
Wex J, Connolly M, Schneider D, Rath W, Nielsen SK. Atosiban is cost saving when compared to beta-mimetics in the treatment of preterm labour in Germany. European Congress of Perinatal Medicine September 2008.
Connolly M, Bhatt A, Wechowski J, Colli I. An economic evaluation of vasoactive agents used to treat acute bleeding oesophageal varices in Belgium. Acta Gastro-enterologica Belgica 2008; 71:230-236.
Nielsen S, Connolly M, Persson BE. Variation between countries in the perceived use of antiandrogens to prevent flare symptoms: results of a comprehensive survey. EAU Milan 2008: (http://www.eaumilan2008.org/typo3conf/ext/eau_abstracts/abstracts/Poster%20session%2032/539-Nielsen.pdf).
Moul JW, Wiederkehr D, Connolly M, Sendersky V, Onel E. The relationship between LHRH-agonist depot formulations and frequency of follow-up with health care providers in patients with prostate cancer. J Clin Oncol 26: 2008 (May 20 suppl; abstr 16002).
Moul JW, Wiederkehr D, Sendersky V, Connolly M, Stern L, Onel E. The influence of Medicare reform on the utilization of anti-androgens in a cohort of patients with prostate cancer in the United States. American Society of Clinical Oncology 2008 (Abstract 204).
Wechowski J, Connolly M, Schneider D, McEwan P, Kennedy R. Cost saving treatment strategies in IVF: A combined economic evaluation of two large randomized clinical trials comparing HP-hMG and rFSH alpha. Fertility & Sterility; 2008.
Svensson A, Connolly M. Long Term Fiscal Implications of subsidizing in-vitro Fertilization in Sweden - A study using Net Present Value. Nordic Fertility Society Jan 2008; Oslo, oral presentation.
Connolly MP, Hoorens S, Gallo F, Ledger W. Assessment of long term economic benefits associated with in-vitro fertilization funding decisions: A simplified lifetime tax calculation. Value in Health 2007;10(6):ES7.
Nielsen SK, Connolly MP, Bhatt A, Currie CJ. Evaluation of the cost-effectiveness of concomitant oral and topical mesalazine treatment versus oral treatment alone in mild-to-moderate active ulcerative colitis: A decision-analytic model. Value in Health 2007;10(6):A353.
SK Nielsen, CJ Currie, MP Connolly, A Bhatt. Evaluation of improvement in health-related quality of life using oral mesalazine alone or in combination with mesalazine enema in active ulcerative colitis: Results from a randomised controlled trial. Value in Health 2007; 10(6):PR8.
Connolly MP, Nielsen SK, Bhatt A, Currie CJ, Probert CS, Marteau P. Evaluation of the cost-effectiveness of concomitant oral and topical versus oral mesalazine therapy in mild-to-moderate active ulcerative colitis: A decision-analytic model. UEGW, Paris MON-G-308, 01 October 2007. Syndicated in PharmacoEconomics & Outcomes News (542):8, December 1, 2007.
Connolly MP, S. Hoorens, and W. Ledger Money in babies out: Assessing the long-term economic impact of IVF conceived children. J. Medical Ethics 2008;34:653-4.
J Wechowski, P McEwan, MP Connolly, R Kennedy. HP-hMG (Menopur®) is cost-saving in IVF compared to rFSH (Gonal-F®) in an economic evaluation using two large combined randomised controlled trials. Human Reproduction 2007; 22(7):O-052.
Connolly MP, Currie CJ, Nielsen SK. Cost-saving treatment strategies in cervical ripening/labour induction: A cost comparison of two dinoprostone formulations. J Perinat Med 2007;35:(S139)
J Wechowski, M Connolly, P McEwan, R Kennedy. An economic evaluation of HP-hMG and rFSH based on a large randomised trial. Reproductive BioMedicine Online 2007;15:500-06.
M Connolly. Demography is destiny: the long term societal impact of assisted reproduction. Portuguese Infertility Society Annual Meeting (Porto), May 19th 2007 (Invited speaker).
J. Wechowski, M Connolly, A Tetlow, P McEwan et al. An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis. Curr Med Res Opin 2007; 23(7):1481-91.
J. Wechowski, P. McEwan, M. Connolly, R. Kennedy. Costs and effectiveness of highly purified human menopausal gonadotropin (HP-hMG) versus recombinant follitropin alpha (rFSH) in IVF treatment: A United Kingdom discrete event simulation model. 19th World Congress on Infertility and Sterility 2007; Durban (oral presentation).
S. Hoorens, F. Gallo, W. Ledger, M. Connolly. The impact of NHS funding decisions for in vitro fertilisation (IVF) on Treasury department revenues: A simplified lifetime net tax calculation. National Institute for Clinical Excellence (NICE) annual meeting, Dec 2006.
L. McCrink, RP. Allen, S. Wolowacz, B. Sherrill, M. Connolly, J. Kirsch. Predictors of health-related quality of life in sufferers with restless legs syndrome: A multi-national study. Sleep Medicine (2006);8(1):73-83.
J. Wechowski, T. Tetlow, Al Woehl, M. Connolly, C.J. Currie, A.K. Burroughs. An economic evaluation of terlipressin versus alternative vasoactive drug treatments for acute oesophageal variceal bleeding in cirrhotic patients: A UK decision-analytic model. 14th United European Gastroenterology Week; 2006: Berlin (256).
Ledger W, Gallo F, Hoorens S, Ziebe S, Connolly M. Present discounted value of children born using IVF compared with naturally conceived children: A simplified UK tax calculation. Hum Rep vol. 21(Suppl 1); 2006 (i74).
Wechowski J, Tetlow T, Woehl A, Currie CJ, Connolly M, Bhatt A, Colle I. Economic evaluation of vasoactive management options for acute oesophageal variceal bleeding in cirrhotic patients: A Belgian comparison. Ceska a Slovenska Gastrologie a Hepatologie 2006;60,S1,119.
Connolly M. Impact of introducing reference-based pricing on prescription drug claims in Australia. 5th European Conference on Health Economics, abstract 63, London, Sept 2004.
| 
